TradingKey

• UBS upgraded Illumina to Buy with a price target of $260. • Illumina will rejoin the S&P 500 index from the S&P MidCap 400. • The company reported strong NovaSeq X demand and consecutive earnings beats.

• Phillips 66 benefited from elevated refining margins and strong global supply constraints. • Quarterly earnings beat expectations, supported by disciplined capital allocation and share buybacks. • Analysts issued rating upgrades while technical indicators suggest overbought conditions for the stock.

• Nvidia named CrowdStrike a premier cybersecurity partner during a major technology conference. • CrowdStrike reported record quarterly net new annual recurring revenue and raised outlook. • The stock showed technical buy signals alongside elevated valuation and intraday volatility.

• Rising commodity prices and favorable analyst revisions drove ConocoPhillips stock higher. • Major field developments were delivered ahead of schedule and below budget. • Annual revenue reached $58.94B with net profit totaling $7.96B.

• Middle East supply disruptions and high refining margins drove Marathon Petroleum's upward momentum. • Bullish analyst coverage and strong operational execution reinforced investor enthusiasm and share buybacks. • Technical indicators show strong buy signals alongside overbought conditions and intraday trading volatility.

• Arrowhead shares dropped despite positive Phase 1/2a data for ARO-DIMER-PA due to profit-taking. • The company reported annual revenue of $829.45M with a net loss of $1.63M. • Technical indicators show a MACD sell signal and an RSI of 27.985.

• Western Digital declined amid broader semiconductor valuation reassessments and macroeconomic headwinds. • Corporate debt adjustments and profit-taking created transient intraday trading friction. • WDC reports annual revenue of $12.92B and net profit of $9.29B.

• Qorvo stock surged amid accelerated merger timelines with Skyworks Solutions. • The FTC waiting period expired without challenge for the transaction. • Technical indicators show a MACD buy signal and overbought Williams %R.

• Ascendis Pharma stock fell after terminating its collaboration agreement with Novo Nordisk. • Investors worry about independent funding and high expenses for obesity clinical programs. • The company reported an annual revenue of $854.80M and net loss.

• Apple's new foldable smartphone launch boosts Skyworks' radio-frequency component demand. • Pending merger with Qorvo entered final regulatory review stages with secured financing. • Management authorized a new multi-billion-dollar share repurchase program to enhance earnings.

OpenAI is advancing measures to address AI safety alongside its key rivals, Anthropic and Google (GOOGL) DeepMind, escalating industry-wide collaborative action in response to growing concerns over the potential economic and security threats posed by AI.

Meta Platforms (META) plans to begin deploying its next-generation in-house AI chips to data centers in the first half of 2027, a move the company says will help save costs and energy when running AI models while reducing its reliance on Nvidia processors.

• Goldman Sachs shares closed lower amid macroeconomic crosscurrents and interest rate uncertainty. • The MACD indicates a sell signal while the Williams %R suggests oversold conditions. • Annual revenue reached $117.10B with net profit totaling $16.30B for the firm.

• Thermo Fisher shares rose following positive management commentary at the healthcare conference. • Executive leadership highlighted recovering client spending in biopharma and life sciences. • The company reported $44.56B in annual revenue and $6.70B in net profit.

• RBC Capital Markets upgraded ResMed to Outperform, raising its price target. • ResMed launched an accelerated share repurchase program funded by MatrixCare divestiture proceeds. • Strong global device revenue and competitor regulatory disruptions supported market share momentum.

• Wolfe Research initiated Ferguson coverage with a neutral rating and cautious outlook. • Macroeconomic headwinds and residential construction softness weighed on core operational demand. • The FloWorks acquisition increased leverage and constrained near-term cash generation.

• UBS shares declined due to European banking sector weakness and macroeconomic uncertainty. • Proposed Swiss capital adequacy regulations and distribution limits weighed on investor sentiment. • UBS reports an annual revenue of $75.76B and net profit of $7.77B.

TradingKey - MSFT closed at $505.41 after a 1.97% gain as Azure growth and AI adoption remain strong. Can $509.82 unlock $517.24-$522.45?

On the day before a crucial Senate procedural vote on the CLARITY Act, Cathie Wood's ARK Invest trimmed its exposure amid a broad rally in crypto stocks, offloading approximately $65 million in crypto-related positions in a single day. The reductions were almost across the board, ranging from its own ARK 21Shares Bitcoin ETF (ARKB) to Coinbase (COIN), Circle (CRCL), BitMine (BMNR), and Bullish (BLSH).

• AMD showed strong upward momentum driven by institutional buying and bullish Wall Street commentary. • Fundamental support relies on expanding Instinct GPU accelerators and EPYC server processor families. • AMD reported annual revenue of $34.64 billion and a net profit of $4.33 billion.